| 标题 |
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncol 作者:Pautier P, Italiano A, Piperno-Neumann S, Chevreau C, Penel N, Firmin N, Boudou-Rouquette P, Bertucci F, Balleyguier C, Lebrun-Ly V, Ray-Coquard I, Kalbacher E, Bardet A, Bompas E, Collard O, Isambert N, Guillemet C, Rios M, Archambaud B, Duffaud F, French Sarcoma Group 出版日期:2022-07-11 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)